In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Spero Therapeutics Inc’s stock clocked out at $2.9, down -1.36% from its previous closing price of $2.94. In other words, the price has decreased by -$1.36 from its previous closing price. On the day, 1.15 million shares were traded. SPRO stock price reached its highest trading level at $3.0 during the session, while it also had its lowest trading level at $2.9.
Ratios:
To gain a deeper understanding of SPRO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.56 and its Current Ratio is at 2.56. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.06.
On September 23, 2022, Evercore ISI Upgraded its rating to Outperform which previously was In-line and also upped its target price recommendation from $2 to $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 05 ’25 when Keutzer Timothy sold 56,537 shares for $0.78 per share. The transaction valued at 44,099 led to the insider holds 741,439 shares of the business.
Rajavelu Esther sold 20,689 shares of SPRO for $16,137 on Feb 05 ’25. The CFO & CBO now owns 724,720 shares after completing the transaction at $0.78 per share. On Feb 05 ’25, another insider, Shukla Sath, who serves as the CEO & President of the company, sold 155,333 shares for $0.78 each. As a result, the insider received 121,160 and left with 1,736,883 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRO now has a Market Capitalization of 164656784 and an Enterprise Value of 117213856. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.73 while its Price-to-Book (P/B) ratio in mrq is 4.79. Its current Enterprise Value per Revenue stands at 2.629 whereas that against EBITDA is -1.602.
Stock Price History:
The Beta on a monthly basis for SPRO is 1.33, which has changed by 1.2222223 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, SPRO has reached a high of $3.09, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is 78.00%, while the 200-Day Moving Average is calculated to be 147.35%.
Shares Statistics:
It appears that SPRO traded 4.16M shares on average per day over the past three months and 1391860 shares per day over the past ten days. A total of 55.90M shares are outstanding, with a floating share count of 37.21M. Insiders hold about 33.45% of the company’s shares, while institutions hold 20.66% stake in the company. Shares short for SPRO as of 1749772800 were 1612678 with a Short Ratio of 0.39, compared to 1747267200 on 636730. Therefore, it implies a Short% of Shares Outstanding of 1612678 and a Short% of Float of 3.52.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
